Eli Lilly's Experimental Amylin-Targeting Drug Shows Promise in Treating Obesity and Type 2 Diabetes
Researchers have identified a promising pathway in the amylin hormone, which is released alongside insulin in the pancreas and helps regulate hunger and fullness.














